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Influenza A virus (IAV) infection during pregnancy causes severe
maternal and perinatal complications, despite a lack of vertical
transmission of IAV across the placenta. Here, we demonstrate a
significant alteration in the maternal vascular landscape that
underpins the maternal and downstream fetal pathology to IAV
infection in mice. In IAV infection of nonpregnant mice, the local
lung inflammatory response was contained to the lungs and was
self-resolving, whereas in pregnant mice, virus dissemination to
major maternal blood vessels, including the aorta, resulted in a
peripheral "vascular storm," with elevated proinflammatory and
antiviral mediators and the influx of Ly6Clow and Ly6Chigh mono-
cytes, plus neutrophils and T cells. This vascular storm was associ-
ated with elevated levels of the adhesion molecules ICAM and
VCAM and the pattern-recognition receptors TLR7 and TLR9 in
the vascular wall, resulting in profound vascular dysfunction.
The sequalae of this IAV-driven vascular storm included placental
growth retardation and intrauterine growth restriction, evidence
of placental and fetal brain hypoxia, and increased circulating cell
free fetal DNA and soluble Flt1. In contrast, IAV infection in non-
pregnant mice caused no obvious alterations in endothelial func-
tion or vascular inflammation. Therefore, IAV infection during
pregnancy drives a significant systemic vascular alteration in preg-
nant dams, which likely suppresses critical blood flow to the pla-
centa and fetus. This study in mice provides a fundamental
mechanistic insight and a paradigm into how an immune response
to a respiratory virus, such as IAV, is likely to specifically drive
maternal and fetal pathologies during pregnancy.
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Influenza A virus (IAV) infection during pregnancy is a veryimportant public health concern, given that women will invari-
ably encounter an influenza season during their term. Pregnant
women are more likely to experience complications associated
with IAV infection, such as acute cardiopulmonary events, pneu-
monia, and acute respiratory distress syndrome. Maternal IAV
infection can also lead to neonatal complications, such as seizures,
cerebral palsy, intrauterine growth restriction (IUGR), preterm
birth, and neonatal death. Moreover, maternal IAV infection has
been strongly associated with long-term health conditions in the
offspring, including cardiovascular disease and schizophrenia (1).
The mechanisms for increased maternal and fetal morbidity/
mortality during IAV infection are currently unknown. Unlike
Zika virus (2), vertical transmission of IAV to the placenta and
fetus does not occur, and, therefore, IAV-induced pathology in
the offspring cannot be attributed to a direct cytolytic effect of the
virus per se. This property of IAV and the pathogenesis it causes
during pregnancy remain poorly characterized.
Pregnancy has profound effects on the maternal cardiovascu-
lar system to support the developing fetus. Increased production
of endothelial nitric oxide (NO) and other vasodilators lead to a
reduction in systemic vascular resistance (25 to 30%), which is
compensated for by increases in cardiac output (up to 40%) and
stroke volume (3, 4). However, abnormal adaptations or vascular
dysfunction during pregnancy can lead to very severe complica-
tions for both the mother and baby. One example is preeclampsia,
a disorder characterized by hypertension and proteinuria, which
can lead to multiorgan failure and even death. Preeclampsia is
associated with chronic immune activation, resulting in endothe-
lial inflammation and dysfunction (5, 6). This placental vascular
disorder develops in part due to an angiogenic imbalance. Pre-
clinical and clinical studies suggest that the significant increase in
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anti-angiogenic soluble fms-like tyrosine 1 (sFLT1) inhibits
proangiogenic factors, such as vascular endothelial growth factor
A (VEGF-A) signaling, consequently prompting vascular alter-
ations and chronic placental under perfusion (7, 8). The reduced
placental blood flow, resulting in IUGR and fetal hypoxia (9), has
significant long-term implications in the adult. Importantly,
women receiving an influenza vaccine during pregnancy have
decreased rates of severe preeclampsia (10). Moreover, pre-
eclampsia significantly increases the risk of future cardiovascular
disease in women, with a fourfold to fivefold increased risk of
developing hypertension (11).
In the present study, we have identified a hitherto-unappreciated
respiratory, placental, and cardiovascular axis of pathology that IAV
drives in dams, which results in complications in the fetus, including
IUGR and fetal hypoxia. A central feature of this IAV pathogenesis
is an exacerbated inflammatory response in the maternal host,
particularly within large blood vessels, including the aorta, resulting
in maternal vascular inflammation and endothelial dysfunction,
contributing to placental and fetal hypoxia. In addition, IAV-
infected pregnant dams are associated with placental stress, as
measured by the release of highly inflammatory cell-free fetal DNA
(CFFDNA) (12), as well as the secretion of the antiangiogenic
protein sFLT1 from the placenta. Of relevance to this study, sFLT1
has been shown to sensitize endothelial cells to proinflammatory
factors (13). Consequently, the release of CFFDNA and sFLT1 into
the maternal circulation promotes an exacerbated systemic inflam-
matory response. Therefore, IAV infection during pregnancy pre-
sents a quashing conundrum for the maternal immune system,
whereby the IAV and the growing fetus become a critical protag-
onist of a "vascular storm," which can ultimately bring upon adverse
health or fatal outcomes for both the dam and offspring. Conse-
quently, influenza in pregnancy should not be considered as an
isolated acute event, but, rather, one that initiates a pathogenic
downstream sequelae of events, which can have profound conse-
quences in the long term for maternal and offspring health.
Results
IAV Infection in Pregnancy Drives an Exacerbated Systemic Inflammatory
Response. Here, we have used a mouse model of IAV infection in
pregnancy that recapitulates pathological and immunological fea-
tures of human IAV infection. We investigated the infection of
pregnant mice at embryonic day 12 (E12) gestation (human equiv-
alent of second trimester of pregnancy) with a moderately patho-
genic strain of IAV (HKx31; 104 plaque-forming units [PFUs]) at a
dose that causes predominantly a local and resolving lung infection
in nonpregnant mice, mimicking seasonal influenza symptoms. In
nonpregnant mice, IAV infection resulted in a significant increase in
airway inflammation at 3 d postinfection (dpi), which was charac-
terized by infiltrating macrophages, neutrophils, and lymphocytes (SI
Appendix, Fig. S1A). In the lung tissue, there was a significant ele-
vation in the expression of the typical proinflammatory cytokines to
IAV infection, including interleukin 6 (IL-6), tumor necrosis factor α
(TNF-α), IL-1β, and interferon-γ (IFN-γ) (SI Appendix, Fig. S1B);
chemokines CCL3 and CXCL2; colony-stimulating factor-3 (CSF-3)
(SI Appendix, Fig. S1C), and antiviral mediator IFN-β (SI Appendix,
Fig. S1D). IAV infection resulted in only a modest systemic in-
flammatory response, with small increases in circulating neutrophils
and lymphocytes, but no alteration in circulating lymphocytes or
platelets (SI Appendix, Fig. S1E). The current paradigm suggests that
the maternal immune system is largely in a state of immunosup-
pression during pregnancy and that this can have a devastating im-
pact on the growing fetus (14). However, it is believed that this
immunosuppression of the antiviral immune response heightens the
risk and severity of an infectious agent such as IAV. In contrast to
this current consensus, we observed a modest, but significantly ele-
vated, airway inflammatory response to IAV infection during
pregnancy, compared to infected nonpregnant mice (SI Appendix,
Fig. S1A). This enhanced airway inflammation was attributed to
heightened macrophage, neutrophil, and lymphocyte infiltration
within the airways of pregnant mice (SI Appendix, Fig. S1A). We
show that proinflammatory cytokines to IAV infection, including
IL-6, TNF-α, IL-1β, and IFN-γ (SI Appendix, Fig. S1B); chemo-
kines CCL3 and CXCL2; CSF-3 (SI Appendix, Fig. S1C); and IFN-
β (SI Appendix, Fig. S1D) were elevated in the lungs of pregnant
mice, but these responses were not significantly different from
those obtained in nonpregnant mice. However, IAV infection in
pregnant mice resulted in significant elevation in systemic in-
flammation, with increases in circulating neutrophils, lymphocytes,
and platelets (SI Appendix, Fig. S1E). Interestingly, IAV in preg-
nancy resulted in elevated numbers of systemic neutrophils, lym-
phocytes, and platelets compared to nonpregnant mice (SI
Appendix, Fig. S1E). Overall, IAV infection in pregnancy resulted
in a local lung inflammatory response that was modestly larger in
magnitude to that observed in nonpregnant mice; however, there
was a significantly larger systemic response, which suggests that
influenza pathology in pregnancy is likely to extend beyond the
lung to include peripheral consequences.
Maternal IAV Infection Is Associated with Placental Growth Retardation
and Hypoxia and Fetal Brain Hypoxia. In corroboration with previous
studies (15, 16), maternal IAV infection did not result in direct
transplacental transmission of the virus to the fetus. At 3 dpi, we
noted no IAV messenger RNA (mRNA) in the placenta of in-
fected dams or in fetal brain (Fig. 1 A and F). Despite a lack of
transplacental infection, we observed significant signs of placental
dysfunction, fetal distress, and developmental complications. At
both 3 and 6 dpi, there was a significant ∼10 to 20% reduction in
pup and placental weights, but no alterations in the number of
resorbed pups (Fig. 1B). In addition to placental and fetal growth
restriction in the offspring of IAV-infected dams (Fig. 1B), we
observed a hypoxic response in the placenta at 6 dpi, but not at 3
dpi (Fig. 1C), as evidenced by a significant increase in the ex-
pression of hypoxic-inducible factor 1α (HIF-1α) and heme oxy-
genase 1 (HMOX1; Fig. 1C). Several studies have reported the
deleterious effects on placenta and fetal development of elevated
IFNs during pregnancy (17, 18). Although we did not detect virus
in the placentas, type I IFNs were elevated in response to ma-
ternal IAV infection. IFN-β expression was 10-fold higher in the
placenta at 6 dpi, but not at 3 dpi (Fig. 1D). In a similar fashion to
the placenta, we noted a hypoxic response to IAV infection in fetal
brains at 6 dpi, but not at 3 dpi (Fig. 1G). This included significant
increases in HIF-1α and HMOX1 (Fig. 1G). Based on the hypoxic
gene profiles in the placenta and fetal brain, maternal IAV in-
fection generates a systemic inflammatory phenotype that is con-
ducive for fetal hypoxic conditions, leading to placental growth
retardation, fetal IUGR, and fetal brain hypoxia.
Maternal IAV Infection Is Associated with Placental and Fetal Brain
Angiogenesis. The maternal cardiovascular system undergoes
profound changes during pregnancy to support the developing
fetus (3). Abnormal adaptations or vasculature perturbations in
pregnancy can lead to severe complications for both the mother
and the developing fetus, including hypertension and pre-
eclampsia. Our findings thus far indicate that maternal IAV is
associated with placental and fetal brain hypoxia. Given that
hypoxia is a powerful stimulus for angiogenesis, we described the
effect of maternal IAV infection on the expression of the an-
giogenic markers VEGF-A and placental growth factor (P1GF)
in the placenta and fetal brain. VEGF-A has been shown to
regulate all steps of the angiogenesis process in the placenta, and
inhibition of PlGF has been shown to suppress inflammation and
pathological angiogenesis (19), while ameliorating maternal hy-
pertension and preeclampsia in mice (20). Placental expression
of angiogenic factors VEGF-A and PlGF, which bind to FLT1,
were significantly up-regulated in pregnant dams following IAV
infection at 6 dpi, but not at 3 dpi, a result consistent with the






























































temporal aspects of hypoxia (Fig. 1E). In addition, we showed
that placental gene expression of FLT1 was significantly in-
creased in dams infected with IAV infection when compared to
controls (Fig. 1E). Matrix metalloproteases (MMPs) play crucial
roles in the extracellular matrix remodeling of the placenta and
pregnancy complications including preterm birth and pre-
eclampsia (21, 22). Furthermore, we observed increased pla-
cental MMP-9 expression in IAV-infected dams when compared
to uninfected controls (Fig. 1E). We also assessed critical ele-
ments of the renin–angiotensin system, including the angiotensin
AT1 and AT2 receptors, both of which were increased in the
placentas of IAV-infected dams (SI Appendix, Fig. S2A). Pla-
cental hypoxia and angiogenesis can drive the release of highly
inflammatory growth factors and CFFDNA. We noted elevated
serum levels of sFLT1 (a marker of vascular inflammation and a
protein that is elevated in preeclampsia) and cell-free levels of
the SRY gene (a male-specific gene which, when elevated in
maternal circulation, could be indicative of increased trophoblast
apoptosis and fetal distress) in IAV-infected dams (Fig. 1I). In-
triguingly, IAV infection was also associated with significantly
Fig. 1. Seasonal IAV infection in pregnant mice is associated with placental and fetal brain hypoxia and angiogenesis. Eight- to 12-wk-old pregnant (E12
gestation) C57BL/6 mice were i.n. inoculated with PBS or Hk-x31 (X-31; 104 PFU) for fetal assessment at 3 dpi (D3) and 6 dpi (D6). (A) IAV burden in placenta
was quantified using qPCR by measuring the mRNA expression of the IAV segment 3 polymerase (PA). (B) Representative images showing pups from PBS- and
X-31–infected dams. Pup weight (grams), placental weight, and number of resorption sites were recorded per dam. (C) Placental mRNA expression of hypoxic
markers, HIF-1α and HMOX-1. (D) Placental expression of cytokine IFN-β. (E) Expression of angiogenesis markers VEGF-A, PGF, FLT-1, MMP9. (F) IAV poly-
merase (PA) mRNA expression in fetal brain. (G and H) Fetal brain mRNA expression of hypoxic markers HIF-1a and HMOX-1 (G) and angiogenesis markers
VEGF-A and PlGF, ICAM1, and VCAM1 (H). (I) Circulating levels of sFLT in maternal plasma was measured by enzyme-linked immunosorbent assay. Quanti-
fication of circulating CFFDNA in maternal plasma was performed by ddPCR by measuring the ratio of the SRY gene (Y chromosome gene, fetal-derived)
against GAPDH (maternal- and fetal-derived). Data are represented as mean ± SEM (pregnant PBS, n = 6 to 10; pregnant X-31, n = 6 to 10 of at least two or
three independent experiments). All fold-change calculations of the X-31 group were measured via qPCR, performed against the PBS group within its re-
spective timepoint, and normalized against GAPDH. Statistical analysis was performed by using an unpaired t test against the respective PBS control. *P <
0.05; **P < 0.01; #P < 0.0001.










































elevated expression of the angiogenic markers VEGF-A and
P1GF, as well as ICAM and VCAM in fetal brains at 6 dpi
(Fig. 1H). Overall, IAV infection in pregnant dams is associated
with an aberrant hypoxic and angiogenic response in the placenta
and fetal brains, which may explain the reduced placental weight
and fetal growth restriction evident following maternal IAV
infection.
IAV Infection during Pregnancy Resulted in a Profound Dysfunction of
the Major Arteries, Including the Maternal Aorta, and Was Associated
with Fetal Growth Retardation.Given that maternal IAV infection is
associated with a hypoxic response in the placenta and fetal brain
with a concomitant reduction in placental and fetal development,
we hypothesized that IAV modifies the maternal vasculature
landscape, particularly the large arteries including the aorta, and, in
doing so, compromises blood flow to the placenta. To investigate
vascular function, we first performed a series of functional experi-
ments on maternal aortas using wire myography. We assessed both
endothelial and smooth-muscle function using the endothelium-
dependent vasodilator acetylcholine (ACh) and the endothelium-
independent vasodilator sodium nitroprusside (SNP), respectively.
At 3 dpi, IAV significantly impaired the ability of the thoracic aorta
to relax in response to ACh with an impairment in both potency and
efficacy (Fig. 2A). There was also a significant impairment in the
relaxation response to SNP (Fig. 2B). Moreover, the endothelium-
dependent aortic dysfunction in pregnant dams persisted until day
6 post-IAV infection (Fig. 2A). Strikingly, IAV infection of non-
pregnant females had no effect on either ACh- or SNP-dependent
relaxation in the aorta (Fig. 2C), strongly suggesting that this effect
by IAV is pregnancy-specific. These findings demonstrated that
IAV infection impairs normal vascular function in pregnancy, and,
given that endothelial function was almost abolished by the infec-
tion, we speculate that this vascular phenotype will significantly
impair blood flow and nutrient transfer to the placenta and fetus,
contributing to placental hypoxia. The effect of IAV on vascular
function is, therefore, analogous to the vascular dysfunction ob-
served in mild and severe preeclampsia. We propose that IAV
drives a preeclampsia-like syndrome during pregnancy and that this
is exacerbated by IAV-induced release of hypoxic, angiogenic, and
inflammatory mediators at the placental membranes.
IAV Infection during Pregnancy Results in IAV Dissemination into the
Aorta and a Proinflammatory and Pro-Oxidative Vascular Inflammatory
Response. The immune system is known to play a central role in
the pathogenesis of endothelial dysfunction in preeclampsia, as
well as hypertension (23–25) and cardiovascular diseases such as
atherosclerosis and myocardial infarction. Given that IAV caused
impairment in vascular relaxation, we next assessed the effect of
IAV on aortic inflammation. First, we detected IAVmRNA in the
aorta of pregnant mice using qPCR, indicating that IAV dissem-
inates peripherally, reaching this large blood vessel at 3 dpi
(Fig. 3A). Interestingly, pregnancy was associated with a 10-fold
higher level of viral mRNA compared to nonpregnant mice
(Fig. 3A). Aortic viral dissemination was associated with a robust
inflammatory response in the aorta, which is exacerbated during
pregnancy. Specifically, we observed increased mRNA expression
of antiviral mediator (IFN-γ) and proinflammatory cytokines (IL-
1β and TNF-α) (Fig. 3 B and C). The pattern-recognition recep-
tors TLR7 and TLR9 were also up-regulated in IAV-infected
aortas, and these responses in the aorta persisted at 6 dpi
(Fig. 3D). The NADPH oxidase 2 (NOX2) oxidase subunit is lo-
calized specifically to subcellular compartments called endosomes
and is the primary source of inflammatory cell reactive oxygen
species (ROS) during IAV infection (26–32). NOX2 expression
was increased in the aortas at 6 dpi, indicative of oxidative stress
(Fig. 3E and SI Appendix, Fig. S3). NOX2 oxidase-dependent
superoxide anion has been shown to react with and inactivate
endothelial-derived NO and, in the process, generates the highly
toxic reactive nitrogen species peroxynitrite. As NO potently
regulates vascular function, the formation of peroxynitrite nega-
tively impacts NO bioavailability (33). In the pregnant influenza-
infected group, oxidative stress was significantly elevated, with
increased peroxynitrite deposition in the aorta, including distinct
“hot pockets” of oxidative stress in the perivascular fat (Fig. 3E).
These distinct hot pockets could possibly contain immune-cell
subsets such as T cells and inflammatory macrophages and are
characteristic of artery tertiary lymphoid organs (34). There was
no alteration in aortic endothelial nitric oxide synthase (eNOS)
mRNA expression at day 3, but an elevation was observed at 6 dpi
(Fig. 3F). This increase in eNOS at 6 dpi could be indicative of an
elevated level of uncoupled eNOS, which becomes an additional
critical source of superoxide anion that contributes to vascular
dysfunction (33). Moreover, there was a significant up-regulation
in the expression of phosphodiesterase type 5A (PDE5A), a crit-
ical enzyme that drives cyclic guanosine monophosphate break-
down and metabolism, which will also contribute to vascular
dysfunction (Fig. 3F). Following IAV infection, there was an in-
crease in the expression of both angiotensin AT1 and AT2R (SI
Appendix, Fig. S2B) in the aorta, which is a critical receptor for
vasoconstriction in response to Ang II. We also observed a sig-
nificant elevation in aortic levels of the adhesion molecules
(ICAM and VCAM) (Fig. 3G). We assessed the same inflam-
matory markers in nonpregnant mice infected with IAV. In con-
trast to pregnant mice, IAV failed to modify the expression of
these markers at day 3, and this is consistent with IAV failing to
modify the function of the aorta of nonpregnant mice at this time
point. It is possible that IAV might modify the vascular function in
nonpregnant mice after 6 dpi. However, we anticipate that this is
unlikely and probably less inflammatory for two reasons. The first
is that at 3 dpi, the IAV viral load within the lungs reaches a peak,
and this coincides with the peak of the host innate immune re-
sponse. Therefore, any alterations induced by the host inflam-
matory response should have manifested at day 3 in the aorta. The
second is that in nonpregnant mice, IAV had no effect on IFN-γ
and CD69 expression at day 3, compared to a significant elevation
in these markers in pregnant mice. These findings suggest that
inflammation in the vascular wall is minimal in nonpregnant mice
at the peak of the innate immune response in this mouse model
and relatively less than that seen in pregnant mice. Together, these
findings demonstrate that, during pregnancy, IAV infection drives
a profound aortic inflammatory response, most likely when the
virus disseminates into the aorta, and this has dire consequences
for its function. The IAV dissemination into the aorta is conducive
to driving 1) a decrease in NO bioavailability by NOX oxidase-
derived oxidative stress, and 2) an increase in the vessel adhe-
siveness to inflammatory cells in the form of adhesion molecule
up-regulation.
IAV Infection during Pregnancy Results in a Vascular Storm Characterized
by Retention of Patrolling Ly6Clow Monocytes and Elevated Ly6Chigh
Proinflammatory Monocytes, Neutrophils, and T Cells in the Aorta. We
next examined whether there was an infiltration of inflammatory
cells into the aorta following IAV infection. There are two subsets
of monocytes that have functional effects on blood vessels, Ly6Clow
monocytes, or “patrolling” monocytes, and Ly6Chigh monocytes,
which are proinflammatory. Ly6Clow monocytes are “accessory
cells” of the endothelium, due to their patrolling function on the
luminal side of the vessel. A critical means of regulating Ly6Clow
monocyte function is via TLR7 activation, which is highly expressed
in these cells. TLR7 is a nucleic-acid-pattern recognition receptor
(PRR) that senses single-stranded RNA (ssRNA), including that
from IAV. TLR7 activation increases Ly6Clow monocyte retention
time on the endothelium and orchestrates the focal necrosis of
endothelial cells, which then recruits neutrophils (35). TLR7-
dependent necrosis is rapid and leaves the basal lamina, tubular
epithelium, and glomerular structures intact. Therefore, Ly6Clow






























































monocytes behave as “gatekeepers” of the vasculature, although it is
easy to conceive that their action on endothelium during pregnancy
might compromise vascular function and blood flow to the growing
fetus. Thus far, we have shown that several signaling elements were
detected or up-regulated at the aorta following IAV infection for
the recruitment of monocytes, including; 1) IAV, 2) TLR7, and 3)
ICAM up-regulation as the adhesion molecule for Ly6Clow mono-
cytes (35). To examine this further, we characterized the infiltrating
leukocyte subpopulations by performing a series of flow-cytometry
analyses at both 3 and 6 dpi. At day 3 post-IAV infection, there was
a significant elevation in patrolling CD11b+Ly6Clow monocytes,
CD11b+Ly6Chigh proinflammatory monocytes, and Ly6G+CD69+
activated neutrophils in the aorta (Fig. 4 A and B). This innate
immune response in the aorta increased by almost 10-fold at 6 dpi
with a remarkable increase in CD11b+Ly6Clow monocytes,
CD11b+Ly6Chigh proinflammatory monocytes, and Ly6G+ neutro-
phils (Fig. 4 A and B).
T cells are key contributors to vascular dysfunction in hyper-
tension (23) via their release of IFN-γ and consequent produc-
tion of ROS and impairment of NO bioavailability. ROS
production by T cells is an indirect process. Evidence suggests
that activated vascular T cells indirectly increase NOX1 and
NOX2 oxidase subunits’ expression through the release of in-
flammatory mediators such as TNF-α (23, 36). Therefore, we
examined whether IAV modified the numbers of circulating
subpopulations of these T cells, which infiltrated the aorta at 6
dpi (SI Appendix, Fig. S4). Overall, we found that there were no
significant alterations in circulating CD8+ and CD4+ T cells (SI
Appendix, Fig. S4). Moreover, there were no changes in activated
CD8+ and CD4+ T cells (SI Appendix, Fig. S4). At day 3 post-IAV
infection, there were no significant alterations in T cell pop-
ulations in the aorta, including CD8+, CD4+, and CD4+ FoxP3+
regulatory T cells (Tregs) or in their phenotype, i.e., CD69+ and
CD44+ (Table 1 and SI Appendix, Fig. S7). These data suggest
that only an innate immune response is occurring in the aorta at
this early day-3 time point after infection. While there were no
significant alterations in T cell populations in the aorta at 3 dpi,
there was a substantial elevation in CD8+ and CD4+ T cells and
their activation, i.e., there was enhancement in their CD69+ and
CD44+ status, at 6 dpi (Table 1 and SI Appendix, Fig. S7). Also,
we assessed the expression of T cell activation markers in IAV-
infected pregnant aortas. CD69 mRNA expression (a marker of
early T cell activation) in IAV-infected pregnant aortas was up-
regulated during the early phase (3 dpi) and persisted during the
later phases (6 dpi) of infection (Fig. 5). We confirmed CD69
expression with immunofluorescence, and an array of CD69-
positive cells were detected in the aorta, particularly lining the
endothelium, and within the peri-adventitial space and sur-
rounding vaso-vasorum (Fig. 5 and SI Appendix, Fig. S5). These
CD69 cells were located within specific pockets of the vascular
walls and effectively visualized sites of pathogenesis.
Discussion
These findings collectively demonstrate that IAV infection in
pregnancy initiates a profound vascular inflammatory response,
which we have termed a vascular storm and is defined as a dis-
turbed state of the vasculature that alters vascular homeostasis.
This is marked by a significant and excessive infiltration of ac-
tivated innate and adaptive immune cells, together with the
overproduction of proinflammatory cytokines IL-1β and TNF-α,
adhesion molecules ICAM and VCAM, and oxidative stress
mediator NOX2 within the vasculature in response to IAV. We
suggest that this resulting aortic inflammation disrupts vascular
homeostasis and leads to the extensive vascular dysfunction.
Intriguingly, while we showed a significant level of IAV mRNA
at 3 dpi in the aorta, at day 6, the level of IAV mRNA expression
had almost returned to undetectable levels. Therefore, in a
similar fashion to lung inflammation, we hypothesize that the
aortic inflammatory response characterized here is critical for
Fig. 2. IAV infection causes vascular dysfunction in pregnant mice. Vascular reactivity was measured in isolated maternal thoracic aortic rings of pregnant
and nonpregnant mice inoculated with PBS or Hk-x31 (X-31; 104 PFU) for assessment at 3 dpi (D3) and 6 dpi (D6). (A) Endothelium-dependent vasodilation to
ACh. (B) Endothelium-independent vasodilation to SNP. (C) Endothelium-dependent (ACh) and independent (SNP) vasodilation was also performed in
nonpregnant mice at 3 dpi. Vascular relaxation is calculated as a percentage of preconstriction to U-46619. Data are represented as mean ± SEM (pregnant
PBS, n = 6 to 8; pregnant X-31, n = 6 to 8; nonpregnant PBS, n = 6 of at least two independent experiments). Statistical analysis was conducted by using a two-
way ANOVA followed by Holm’s Sidak post hoc multiple comparison. *P < 0.05; #P < 0.0001.










































clearing IAV infection from the vasculature, but with potentially
deleterious off-target effects to the developing offspring.
Taken together, we have identified major components of a
severe immune overreaction to IAV in the maternal vasculature.
This vascular inflammation during maternal IAV infection en-
tails an early innate immune response, characterized by the in-
filtration of monocytes, macrophages, and neutrophils at blood
vessels, followed by an adaptive immune response with T lym-
phocyte infiltration. This is associated with a substantial decrease
in capacity of the blood vessels to vasodilate that is specifically
necessary for blood flow toward the growing fetus. Intriguingly,
the same IAV infection resulted in either no or a very mild
vascular inflammatory response in nonpregnant mice. From our
observations, we speculate that this robust vascular inflammation
following maternal IAV infection is driven by several signaling
elements, including 1) two danger signals, i.e., foreign patho-
genic IAV and semiforeign CFFDNA, acting synergistically to
trigger systemic inflammation; 2) elevated levels of circulating
sFLT1 in maternal circulation; 3) up-regulation of aortic TLR7
(ssRNA sensor) and TLR9 (DNA sensor); 4) up-regulation of
adhesion molecules for Ly6Clow monocyte retention to the vas-
cular wall; 5) recruitment and activation of neutrophils and T
lymphocytes; and 6) NOX2 oxidase-derived superoxide anion
production in the aorta. We have previously identified that IAV
Fig. 3. IAV disseminates into the aorta and drives a proinflammatory and oxidative stress response in the maternal vasculature. Pregnant and nonpregnant
female mice were inoculated with PBS or Hk-x31 (X-31; 104 PFU) for aortic assessment at 3 dpi (D3) and 6 dpi (D6). (A) Viral burden in maternal thoracic aorta
was quantified using qPCR by measuring the IAV segment 3 polymerase (PA). (B and C) Thoracic aorta gene expression of antiviral mediator IFN-γ and
proinflammatory cytokines TNF-α and IL-1β. (D) Aortic mRNA expression of pattern recognition receptors TLR7 and TLR9. (E) Immunofluorescence microscopy
of pregnant PBS- and Hk-x31–infected mice labeled with 3 nitro tyrosine (3nt) antibody (green). Arrows show areas of dense peroxynitrite production. Also
shown are the quantification results and oxidative stress marker NOX2 gene expression. (F) Endothelial NO signaling PDE5A and eNOS expression in the aorta.
(G) Adhesion molecule ICAM1 and VCAM1 gene expression. Data are represented as mean ± SEM (pregnant PBS, n = 6 to 8; pregnant X-31, n = 6 to 8;
nonpregnant PBS, n = 6 of at least two or three independent experiments). All fold-change calculations of the X-31 group were measured via qPCR, per-
formed against the PBS group within its respective timepoint and normalized against GAPDH. Statistical analysis was performed by using unpaired t test
against the respective PBS control. *P < 0.05; **P < 0.01; ***P < 0.001; #P < 0.0001.






























































promotes endosomal NOX2-derived ROS and mitochondrial
ROS (mtROS) production, which can exacerbate IAV patho-
genesis by driving innate immune inflammation (37). Blockade of
mtROS by (2-(2,2,6,6-Tetramethylpiperidin-1-oxyl-4-ylamino)-2-
oxoethyl)triphenylphosphonium chloride (mitoTEMPO) reduced
innate immune-cell infiltration and their cytokine production
without affecting the adaptive immune response and, thus, clear-
ance of the virus (37). Therefore, targeting endosomal NOX2-
derived ROS and mtROS production may be a potential thera-
peutic strategy for IAV in pregnancy by alleviating systemic and
vascular inflammation.
In conclusion, we identified a hitherto-unappreciated pathol-
ogy of IAV infection in pregnancy, which results in severe
complications in the dams and offspring. Here, we provide evi-
dence that IAV can disseminate into the aorta of pregnant mice
to trigger a vascular storm event, which causes profound endo-
thelial dysfunction of the major arteries, resulting in fetal dis-
tress, as characterized by placental and fetal brain hypoxia, as
well as increasing circulating levels of CFFDNA and sFLT1. Our
work challenges the current dogma of pregnancy-dependent
immunosuppression and provides unequivocal evidence of an
exacerbated immune system response to IAV in pregnancy and
that this concomitantly impacts on the cardiovascular system.
Our findings show a remarkable similarity in pathologies be-
tween IAV infection and preeclampsia and might therefore im-
prove our understanding of how viral infections could trigger
preeclampsia, or other hypertensive disorders, in pregnancy.
Moreover, our findings in the pregnant mouse model highlight
the need for specific studies in pregnant women to improve our
understanding on the pathogenesis of IAV infection on the
maternal cardiovascular system.
Materials and Methods
Animal Ethics Statement. All animal experiments described in this manuscript
were approved by the Animal Experimentation Ethics Committee of the Royal
Melbourne Institute of Technology (RMIT) University Animal Ethics Com-
mittee (Ethics no. 1801). The experiments were conducted in compliance with
the guidelines of the National Health and Medical Research Council of
Australia on animal experimentation.
Animals. Eight- to 12-wk-old pregnant and age-matched nonpregnant fe-
male C57BL6/J mice were obtained from the Animal Resources Centre
Western Australia and housed in the animal research facility (RMIT
Fig. 4. IAV infection promotes innate inflammation via the infiltration of monocytes and neutrophils in the aorta of pregnant mice. Single-cell suspensions
were prepared from whole thoracic aorta digests from pregnant mice inoculated with either PBS or Hk-x31 virus (X-31; 104 PFU) at 3 dpi (D3) and 6 dpi (D6)
and quantified for the following cell subsets via flow cytometry. Representative dot plots and quantification are shown. (A) Patrolling monocytes
(CD11b+Ly6Clow) and proinflammatory monocytes (CD11b+Ly6Chigh). (B) Ly6G+ neutrophils and CD69+ activated neutrophils. All cell populations are measured
as absolute number of CD45+ population per 25,000 counting beads. Data are represented as mean ± SEM (pregnant PBS, n = 5 or 6; pregnant X-31, n = 5 or 6;
of at least two independent experiments). Statistical analysis was performed by using unpaired t test against their respective PBS control. *P < 0.05; **P <
0.01; ***P < 0.001.
Table 1. Quantification of aortic memory T helper (CD44hi CD4+) and cytotoxic (CD44hi CD8+)
T cells and Treg (FOXP3+ CD4+) cells by flow cytometry between IAV-infected and control dams
Pregnant 3 dpi Pregnant 6 dpi
PBS (n = 7) X-31 (n = 9) P value PBS (n = 7) X-31 (n = 7) P value
CD44hi CD4+ T cells 523 403 0.353 4,190 11,448 0.027
CD44hi CD8+ T cells 536 307 0.262 2,230 11,775 0.008
FOXP3+ CD4+ cells 2,214 2,401 0.463 3,337 6,587 0.054
Data are represented as absolute cell numbers. Statistical analysis was performed using unpaired t test against
their respective PBS control. Boldface text indicates significance; P < 0.05 was considered significant.










































University) under standard conditions. Mice were placed in groups of three
or four in separate cages.
Virus. The Hk-x31 (H3N2) mouse-adapted IAV strain was provided by Patrick
Reading, Department of Immunology and Microbiology, The Peter Doherty
Institute for Infection and Immunity, University of Melbourne, Melbourne.
Virus aliquots were provided in phosphate-buffered saline (PBS, catalog no.
D8537, Sigma) at 9.6 × 107 plaque-forming units (PFU)/milliliter and stored
at −80 °C until required.
In Vivo Infection with IAV. Pregnant mice at E12 gestation (second trimester)
and age-matched-nonpregnant female mice (n = 6 to 8 per group) were
sedated with isoflurane inhalation and inoculated intranasally (i.n.) with
35 μL of 104 PFU of Hk-x31 virus diluted in PBS or mock infected with PBS
only at day 0. Mice were then weighed and monitored daily.
Airway Inflammation, Cell Differentials, and Blood Analysis. At study end-
points, nonpregnant mice were euthanized at day 3 and pregnant mice
on day 3 or 6 via an intraperitoneal injection of ketamine (180 mg/kg)/
xylazine (32 mg/kg) mixture, and organs were harvested. To assess airway
inflammation, the lower jaw to the top of the rib cage was incised to expose
salivary glands, whichwere then separated to expose the smoothmuscle layer
on the surface of the trachea. The smooth muscle layer was removed, and a
small incision was made near the top of the trachea. A sheathed 21-Gauge
needle was then inserted into the lumen, and the lung was lavaged with 300
to 400 μL of PBS repeatedly and transferred to an Eppendorf tube. Cell-
viability assessment involved staining total bronchioalveolar lavage fluid
(BALF) cells with 10 μL of ethidium bromide solution (catalog no. 15585011,
Thermofisher Scientific) and transferred to a hemocytometer to quantify the
total number of viable cells.
Differential cell analysis was prepared from BALF by centrifugation of 5 ×
104 cells on the Cytospin 3 (Shandon) at 112 × g for 5 min. Slides were fixed
for 1 min in propan-2-ol and air-dried in a fume hood overnight. The sam-
ples were then stained with Rapid I Aqueous Red StainTM (catalog no. RS1-
1L, AMBER Scientific) for 5 min and rinsed thoroughly in water and Rapid II
Blue StainTM (catalog no. RS11-1L, AMBER Scientific) for 5 min, before being
washed thoroughly again in water. Slides were submerged once in 70%
ethanol and twice in absolute ethanol prior to being placed twice into his-
tolene (Grale Scientific, catalog no. 11031/5) for 5 min each. Samples were
then mounted in dibutylphthalate polystyrene xylene mounting medium
(catalog no. AJA3197-500ML, Labchem) and coverslipped. Analysis involved
counting random fields of differentiated cells, including macrophages,
neutrophils, and lymphocytes, to a total of 500 cells per sample by standard
morphological criteria.
Blood was retrieved by performing a cardiac puncture to obtain between
0.3 and 1 mL of blood. For flow-cytometric analysis, 0.1 mL of clexane was
pumped into the heart before blood was collected, and the amount re-
trieved was recorded. Blood differential analysis involved the use of the
CELL-DYN emerald 22 hematology analyzer (Abbott), and, subsequently, the
blood was centrifuged at 10,000 × g for 10 min at 4 °C to retrieve plasma to
be stored at −80 °C.
Quantification of mRNA by qPCR. Maternal lung, thoracic aorta, three pla-
centas, and fetal brains per dam were harvested from mice and fetus per
experimental group on 3 or 6 dpi for RNA extraction using the RNeasyMini kit
(catalog no. 74104, Qiagen) as per manufacturer’s instructions. RNA sample
concentration and quality were measured by using the Nanodrop 2000
Spectrophotometer (Thermo Scientific). The complementary DNA (cDNA)
synthesis was performed on 1.0 to 2.0 μg of total RNA by using the High-
Capacity cDNA Reverse Transcription Kit (catalog no. 4368814, Applied
Biosystems). Total RNA was added to a mastermix mixture of reagents in the
Fig. 5. IAV infection promotes an adaptive immune T cell response in the aorta of pregnant mice. Mice were inoculated with either PBS or Hk-x31 virus (X-31;
104 PFU) at 3 dpi (D3) and 6 dpi (D6). Immunofluorescence microscopy of pregnant PBS- and Hk-x31–infected mice labeled with early T cell activation marker
CD69 antibody (red) are shown. Arrows show areas of positive CD69 cells and α smooth muscle actin (αSMA). Also shown are the quantification results and
CD69 mRNA expression. Data are represented as mean ± SEM (pregnant PBS, n = 5 or 6; pregnant X-31, n = 5 or 6; of at least two independent experiments).
Statistical analysis was performed by using unpaired t test against their respective PBS control. *P < 0.05; ***P < 0.001.






























































High-Capacity cDNA reverse-transcription kit to make a final volume of 20 μL
and transcribed at the following settings: 25 °C for 10 min, 37 °C for 120 min,
and 85 °C for 5 min, and kept at 4 °C until collection using the Veriti Thermal
Cycler (Applied Biosystems).
qPCR was later carried out by using the TaqMan Universal PCR Master Mix
(catalog no. 4304437, Applied Biosystems) or SYBR Green PCR Master Mix
(catalog no. 4367659, Applied Biosystems) when measuring viral polymerase
and analyzed on the Applied Biosystem QuantStudio 7 Flex Real-Time PCR
System (Thermofisher). The PCR primers for TNF-α, IL-1β, IFN-β, IL-6, NOX2,
CD69, CXCL2, CCL3, IFN-γ, AGRT1α, AGRT2, VCAM-1, ICAM-1, PDE5α, VEGF,
HIF-1α, HMOX-1, TLR7, FLT1, MMP9, PlGF, TLR9, and eNOS were included in
the Assay on-Demand Gene Expression Assay Mix (Applied Biosystems). Viral
titers were measured by using oligonucleotide mouse sequence for the
forward and reverse primers of the segment 3 polymerase (PA) of influenza
virus. The quantitative values were obtained from the threshold cycle (Ct)
number. Gene-expression analysis was performed by using the comparative
Ct method. Each sample individual target gene-expression level was nor-
malized against GAPDH mRNA expression, and the data were expressed
relative to the control.
Wire Myograph. Maternal thoracic aortic rings were harvested and dissected
free of perivascular adipose and connective tissue. Harvested vessels were
placed in physiological carbogen-bubbled (95% O2 and 5% CO2) Krebs so-
lution (composition in mmol/L: 119 NaCl, 4.7 KCl, 1.17 MgSO4, 25 NaHCO3,
1.18 KH2PO4, 5.5 glucose, and 2.5 CaCl2). The artery was then cut into 2-mm
rings and mounted onto two stainless-steel pins on four-channel wire
myograph baths (Danish myo Technology) containing Krebs. Vessels were
normalized to a resting tension of 5 mN and allowed to equilibrate for
30 min before exposure to 0.5 × 10−3 M thromboxane A2 agonist U-46619
(catalog no. 56985-40-1, Cayman) to determine maximum smooth-
muscle-dependent vasocontraction. Endothelium-dependent and -indepen-
dent vasodilation were assessed by using increasing concentrations of ACh
and SNP at 1 × 10−9 to 1 × 10−5 M in a submaximally contracted aorta. All
experiments were conducted in duplicates and compared to mock-infected
pregnant and nonpregnant controls.
Flow-Cytometry Analysis. Maternal thoracic and uterine arteries harvested at
3 and 6 dpi were minced by using scissors and digested in a digestion buffer
(composition Collagenase type XI [catalog no. C7657-100MG, Sigma], hyal-
uronidase [catalog no. H3884-50MG, Sigma], and Collagenase Type I-S [cat-
alog no. C1639-50MG, Sigma]) for 1 h with intermittent shakes to make up
cell suspension. Total bone marrow cells were drained from the femur and
tibia by using Hank’s balanced salt solution HBSS (catalog no. 14175095,
Gibco) after hip dislocation and immersion in 70% ethanol. Cells suspensions
were filtered through a 40-μm strainer, centrifuged at 400 × g, and washed
twice with a fluorescence-activated cell-sorting (FACS) buffer. Total viable
cells were then counted, resuspended in PBS, and incubated on ice for
30 min. The cells were then stained for 15 min at 4 °C with antibodies and
washed twice with FACS buffer. The antibody panel used for staining, and in
their different multicolor combinations, were as follows: 1:500 Alexa Fluor
anti-CD45 (30-F11); 1:500 APC anti-CD3 (145-2C11); 1:1,000 PE-Cy7 anti-CD8
(53-6.7); 1:500 BV605 anti-CD4 (RM4-5); 1:500 FITC anti-Ly6C (HK1.4);
1:500 APC-Cy7 anti-Ly6G (1A8); 1:500 BV421 anti-CD11b (M1/70); 1:500
BV650 anti-CD69 (H1.2F3); 1:500 PerCP-CD44 (IM7); 1:1,000 PE anti-FoxP3
(FJK-16s), and live/dead Aqua (catalog no. L34965; Invitrogen). Following
immunostaining, cells were resuspended in FACS buffer, fixed, and analyzed
the following day on the FACARIA II flow cytometry with DIVA software
(Becton Dickinson). Data were analyzed by using FlowJo software (Tree Star,
Inc.). The cells were analyzed as a percentage of the CD45+ (live cells) and
expressed in absolute numbers per 25,000 counting beads. Refer to SI Ap-
pendix, Fig. S6 for gating strategy.
CFFDNA Purification and Quantification. Circulating CFFDNA was extracted
from maternal plasma by using the DNeasy Blood and Tissue Kit (catalog no.
69506, Qiagen) according to the manufacturer’s instructions. DNA concen-
tration and quality were measured by using the Nanodrop 2000 Spectro-
photometer (Thermo Scientific) and stored at −20 °C until use. A total of 10
to 60 ng of DNA was mixed with reagents in digital droplet PCR (ddPCR)
Supermix for Probes (catalog no. 1863024, Bio-Rad Laboratories) and pri-
mers to quantify fetal SRY gene transcripts. Gene expression of total circu-
lating (maternal and fetal) GAPDH levels was also quantified and used to
normalized SRY gene expression. DNA was amplified at the following set-
tings: 95 °C for 10 min, 94 °C for 30 s, 60 °C for 1 min, and 98 °C for 10 min,
and kept at 4 °C until collection using the C1000 Touch thermocycler
(Bio-Rad) and then quantified by using the QXDx ddPCR System (Bio-Rad).
ELISA. Plasma levels of sFlt1 in pregnant mice 3 and 6 dpi was quantified by
using the Mouse sVEGFR1/sFLT1 DuoSet ELISA Kit (catalog no. DY471, R&D
Systems) according to manufacturer’s instructions.
Immunofluorescence Microscopy. Maternal thoracic aorta was fixed in 10%
neutral buffered formalin, embedded in paraffin, and prepared in 5-μm
sections. Tissue sections underwent immunofluorescence staining protocol
and were stained with primary antibody 3 nitro tyrosine (1:100) (AbCam
catalog no. AB61392) to localize oxidative stress in the form of peroxynitrite
and CD69 (1:100) (AbCam catalog no. AB202909) to localize positive CD69
cells. Tissues were imaged by using an Olympus S5 VS-ASW slide scanner and
quantified by two separate blinded investigators via mean positive cell
counts or fluorescence intensity using the Olympus cellSens Dimension
Desktop Analyzer. All of the appropriate controls were performed, in that
all primary and secondary antibodies combinations were used to prevent
cross-reactivity.
Statistical Analysis.All data are expressed as the mean ± SEM. All comparisons
were made within experimental groups and were performed by unpaired
t test or one-way ANOVA followed by either a Kruskal–Wallis test, a
Mann–Whitney U test, or a Tukey’s post hoc test when specific multiple
comparisons were needed. Dose–response curve analysis for vascular reac-
tivity studies was performed by using ANOVA for repeated measures. Sta-
tistical tests were performed by using GraphPad Prism (GraphPad Software,
Version 8.2). Statistical significance was considered at P < 0.05.
Data Availability. All study data are included in the article and SI Appendix.
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